PharmaShots | Incisive News in 3 Shots

Subscribe Now

Nasal Polyposis

Sanofi's Dupixent (dupilumab) Receives the Health Canada Approval for Severe Chronic Rhinosinusitis with Nasal Polyposis

Sanofi's Dupixent (dupilumab) Receives the Health Canada Approval for Severe Chronic Rhinosinusitis with Nasal Polyposis

August 19, 2020

Regeneron and Sanofi's Dupixent (dupilumab) Receives FDA's Approval for Chronic Rhinosinusitis with Nasal Polyposis

Regeneron and Sanofi's Dupixent (dupilumab) Receives FDA's Approval for Chronic Rhinosinusitis with Nasal Polyposis

June 27, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us